ECSP15000868A - Derivados de estra1,3,5(10),16tetraeno 3sustituidos, métodos para su preparación, preparaciones farmacéuticas que los contienen, así como su uso para la preparación de medicamentos - Google Patents
Derivados de estra1,3,5(10),16tetraeno 3sustituidos, métodos para su preparación, preparaciones farmacéuticas que los contienen, así como su uso para la preparación de medicamentosInfo
- Publication number
- ECSP15000868A ECSP15000868A ECIEPI2015868A ECPI201500868A ECSP15000868A EC SP15000868 A ECSP15000868 A EC SP15000868A EC IEPI2015868 A ECIEPI2015868 A EC IEPI2015868A EC PI201500868 A ECPI201500868 A EC PI201500868A EC SP15000868 A ECSP15000868 A EC SP15000868A
- Authority
- EC
- Ecuador
- Prior art keywords
- preparation
- methods
- well
- estra
- tetraene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Abstract
La invención se refiere a inhibidores de AKR1C3 y a métodos para su preparación, su uso para el tratamiento y/o la prevención de enfermedades, así como a su uso para la preparación de medicamentos para el tratamiento y/o la prevención de enfermedades, en especial de trastornos hemorrágicos y endometriosis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102012211970 | 2012-07-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP15000868A true ECSP15000868A (es) | 2016-01-29 |
Family
ID=48748225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECIEPI2015868A ECSP15000868A (es) | 2012-07-10 | 2015-01-09 | Derivados de estra1,3,5(10),16tetraeno 3sustituidos, métodos para su preparación, preparaciones farmacéuticas que los contienen, así como su uso para la preparación de medicamentos |
Country Status (28)
Country | Link |
---|---|
US (1) | US9512169B2 (es) |
EP (1) | EP2872524B1 (es) |
JP (1) | JP6196302B2 (es) |
KR (1) | KR20150036319A (es) |
CN (1) | CN104428309B (es) |
AP (1) | AP2014008179A0 (es) |
AR (1) | AR092025A1 (es) |
AU (1) | AU2013289344A1 (es) |
BR (1) | BR112015000443A2 (es) |
CA (1) | CA2878485A1 (es) |
CL (1) | CL2015000039A1 (es) |
CO (1) | CO7160008A2 (es) |
CR (1) | CR20150007A (es) |
DO (1) | DOP2015000005A (es) |
EA (1) | EA201500112A1 (es) |
EC (1) | ECSP15000868A (es) |
ES (1) | ES2603258T3 (es) |
HK (1) | HK1205743A1 (es) |
IL (1) | IL236581A0 (es) |
MA (1) | MA37742B1 (es) |
MX (1) | MX2015000347A (es) |
PE (1) | PE20150353A1 (es) |
PH (1) | PH12015500062A1 (es) |
TN (1) | TN2015000007A1 (es) |
TW (1) | TW201402596A (es) |
UY (1) | UY34899A (es) |
WO (1) | WO2014009274A1 (es) |
ZA (1) | ZA201500920B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112015018071A2 (pt) * | 2013-02-21 | 2017-07-18 | Bayer Pharma AG | estra-1,3,5(10),16-tetraeno-3-carboxamidas |
JP6407415B2 (ja) * | 2014-09-11 | 2018-10-17 | バイエル・ファルマ・アクティエンゲゼルシャフト | 3−窒素または硫黄置換エストラ−1,3,5(10),16−テトラエンakr1c3阻害剤 |
US10167293B2 (en) | 2016-05-26 | 2019-01-01 | Bayer Pharma Aktiengesellschaft | [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones |
CZ307437B6 (cs) | 2016-06-07 | 2018-08-22 | Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v.v.i. | 15β-substituované deriváty estronu jako selektivní inhibitory 17β-hydroxysteoiddehydrogenáz |
EP3269373A1 (en) | 2016-07-11 | 2018-01-17 | Bayer Pharma Aktiengesellschaft | Low-dosed oral dosage form of an akr1c3 inhibitor for treatment of diseases |
US20200085791A1 (en) | 2016-12-19 | 2020-03-19 | Bayer Pharma Aktiengesellschaft | [(phenylsulfonyl)octahydro-epiminoisoindol-yl](1h-1,2,3-triazol-5-yl)methanones |
TW201825478A (zh) | 2016-12-19 | 2018-07-16 | 德商拜耳製藥公司 | [4-(苯基磺醯基)哌嗪-1--基](1h-1,2,3-三唑-4-基)甲酮 |
WO2018114672A1 (en) | 2016-12-19 | 2018-06-28 | Bayer Pharma Aktiengesellschaft | [4-(phenylsulfonyl)piperazin-1-yl](1h-1,2,3-triazol-4-yl)methanones |
EP3421483A1 (en) | 2017-06-29 | 2019-01-02 | Bayer Pharma Aktiengesellschaft | Novel steroidal 17-beta heteroaryl compounds as inhibitors of akr1c3 |
CN110693892A (zh) * | 2018-07-09 | 2020-01-17 | 深圳艾欣达伟医药科技有限公司 | 化合物用于制备预防、治疗或改善疼痛的药物的用途 |
CN110272465A (zh) * | 2019-07-15 | 2019-09-24 | 成都贝诺科成生物科技有限公司 | 阿比特龙衍生物、其制备方法与应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0633893B1 (en) * | 1992-03-31 | 1999-11-24 | Btg International Limited | 17-substituted steroids useful in cancer treatment |
US5604213A (en) | 1992-03-31 | 1997-02-18 | British Technology Group Limited | 17-substituted steroids useful in cancer treatment |
IL122740A (en) | 1997-01-15 | 2003-09-17 | Akzo Nobel Nv | 16-hydroxy-11-(substituted phenyl)-estra-9,4-diene derivatives, their preparation and pharmaceutical compositions containing them |
BR9809748A (pt) | 1997-04-07 | 2000-06-20 | American Home Prod | Estra-5(10), 7-dienos com atividade estrogênica |
BR9908592A (pt) | 1998-03-11 | 2001-04-24 | Endorech Inc | Processo para inibir a atividade de 17ß-hidroxiesteróide desidrogenase tipo 5, composição farmacêutica, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 5, processo para inibir 17ß-hidroxiesteróide desidrogenase tipo 3, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 3, processos para tratar, ou reduzir o risco de desenvolver, câncer da próstata, hiperplasia prostática benigna, acne, seborréia, hirsutismo ou alopécia androgênica, sìndrome de ovário policìstico, câncer de mama, endometriose ou leiomioma, para inibir as secreções hormonais testiculares, para tratar puberdade precoce, e, kit |
JP2002522380A (ja) | 1998-08-07 | 2002-07-23 | アンドルシェルシュ・インコーポレイテッド | タイプ33α−ヒドロキシステロイドデヒドロゲナーゼの阻害 |
US6953785B2 (en) * | 2000-04-24 | 2005-10-11 | Kyowa Hakko Kogyo Co., Ltd. | Estra-1,3,5(10)-triene derivatives |
WO2005089256A2 (en) | 2004-03-12 | 2005-09-29 | Entremed, Inc. | Antiangiogenic agents |
CN101395134B (zh) | 2006-03-02 | 2011-08-31 | 安斯泰来制药有限公司 | 17β-羟类固醇脱氢酶5型抑制剂 |
RU2453554C2 (ru) | 2006-11-30 | 2012-06-20 | Зольвай Фармасьютиклз Гмбх | Замещенные производные эстратриена как ингибиторы 17бета hsd |
WO2008077810A2 (en) | 2006-12-22 | 2008-07-03 | F. Hoffmann-La Roche Ag | Spiro-piperidine derivatives |
KR20100046107A (ko) | 2007-07-24 | 2010-05-06 | 아스텔라스세이야쿠 가부시키가이샤 | 벤즈이미다졸 유도체 |
DE102011083725A1 (de) * | 2011-09-29 | 2013-04-04 | Bayer Pharma AG | Estra-1,3,5(10),16-tetraen-3-carboxamid-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
-
2013
- 2013-07-05 US US14/414,386 patent/US9512169B2/en not_active Expired - Fee Related
- 2013-07-05 JP JP2015520927A patent/JP6196302B2/ja not_active Expired - Fee Related
- 2013-07-05 EP EP13734744.9A patent/EP2872524B1/de active Active
- 2013-07-05 CN CN201380036684.4A patent/CN104428309B/zh not_active Expired - Fee Related
- 2013-07-05 BR BR112015000443A patent/BR112015000443A2/pt not_active IP Right Cessation
- 2013-07-05 CA CA2878485A patent/CA2878485A1/en not_active Abandoned
- 2013-07-05 ES ES13734744.9T patent/ES2603258T3/es active Active
- 2013-07-05 WO PCT/EP2013/064257 patent/WO2014009274A1/de active Application Filing
- 2013-07-05 MX MX2015000347A patent/MX2015000347A/es unknown
- 2013-07-05 KR KR20157002707A patent/KR20150036319A/ko not_active Application Discontinuation
- 2013-07-05 AP AP2014008179A patent/AP2014008179A0/xx unknown
- 2013-07-05 AU AU2013289344A patent/AU2013289344A1/en not_active Abandoned
- 2013-07-05 EA EA201500112A patent/EA201500112A1/ru unknown
- 2013-07-05 PE PE2015000018A patent/PE20150353A1/es not_active Application Discontinuation
- 2013-07-10 UY UY0001034899A patent/UY34899A/es not_active Application Discontinuation
- 2013-07-10 TW TW102124795A patent/TW201402596A/zh unknown
- 2013-07-10 AR ARP130102438A patent/AR092025A1/es unknown
-
2015
- 2015-01-05 IL IL236581A patent/IL236581A0/en unknown
- 2015-01-07 TN TNP2015000007A patent/TN2015000007A1/fr unknown
- 2015-01-07 MA MA37742A patent/MA37742B1/fr unknown
- 2015-01-08 CL CL2015000039A patent/CL2015000039A1/es unknown
- 2015-01-09 DO DO2015000005A patent/DOP2015000005A/es unknown
- 2015-01-09 CO CO15004249A patent/CO7160008A2/es unknown
- 2015-01-09 PH PH12015500062A patent/PH12015500062A1/en unknown
- 2015-01-09 CR CR20150007A patent/CR20150007A/es unknown
- 2015-01-09 EC ECIEPI2015868A patent/ECSP15000868A/es unknown
- 2015-02-09 ZA ZA2015/00920A patent/ZA201500920B/en unknown
- 2015-07-06 HK HK15106384.4A patent/HK1205743A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1205743A1 (en) | 2015-12-24 |
CN104428309A (zh) | 2015-03-18 |
JP6196302B2 (ja) | 2017-09-13 |
CO7160008A2 (es) | 2015-01-15 |
EP2872524A1 (de) | 2015-05-20 |
ES2603258T3 (es) | 2017-02-24 |
DOP2015000005A (es) | 2015-02-15 |
WO2014009274A1 (de) | 2014-01-16 |
MX2015000347A (es) | 2015-04-14 |
US9512169B2 (en) | 2016-12-06 |
AP2014008179A0 (en) | 2014-12-31 |
TN2015000007A1 (en) | 2016-06-29 |
PH12015500062A1 (en) | 2015-03-02 |
CA2878485A1 (en) | 2014-01-16 |
CR20150007A (es) | 2015-03-13 |
CL2015000039A1 (es) | 2015-03-27 |
ZA201500920B (en) | 2017-01-25 |
CN104428309B (zh) | 2016-09-14 |
IL236581A0 (en) | 2015-02-26 |
PE20150353A1 (es) | 2015-03-28 |
US20150210734A1 (en) | 2015-07-30 |
UY34899A (es) | 2014-02-28 |
MA37742A1 (fr) | 2016-05-31 |
TW201402596A (zh) | 2014-01-16 |
AU2013289344A1 (en) | 2015-02-05 |
AR092025A1 (es) | 2015-03-18 |
EP2872524B1 (de) | 2016-08-24 |
KR20150036319A (ko) | 2015-04-07 |
JP2015522050A (ja) | 2015-08-03 |
BR112015000443A2 (pt) | 2017-06-27 |
MA37742B1 (fr) | 2016-12-30 |
EA201500112A1 (ru) | 2015-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP15000868A (es) | Derivados de estra1,3,5(10),16tetraeno 3sustituidos, métodos para su preparación, preparaciones farmacéuticas que los contienen, así como su uso para la preparación de medicamentos | |
DOP2014000059A (es) | Derivados de estra1,3,5(10),16tetraen3carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos | |
BR112018005497A2 (pt) | compostos heterocíclicos e usos dos mesmos | |
CU20160087A7 (es) | Indazolcarboxamidas, procedimientos para su preparación, preparaciones farmacéuticas que las contienen | |
BR112017022604A2 (pt) | composto, composição farmacêutica, uso de um composto e de uma combinação, e, combinação | |
NI201600144A (es) | Derivados de quinoxalina utiles como moduladores del fgfr cinasa | |
NI201500167A (es) | Compuestos químicos | |
CR20150326A (es) | Inhibidores de autotaxina | |
BR112015011456A2 (pt) | compostos de aminopirimidina como inibidores de egfr mutantes contendo t790m | |
IN2014DN06501A (es) | ||
UA116648C2 (uk) | Фумарати як проліки та їх застосування при лікуванні різних захворювань | |
ECSP12012318A (es) | Inhibidores de pirazolil quinazolina cinasa | |
CU20140081A7 (es) | Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
CU20140095A7 (es) | Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
CO7310531A2 (es) | 4-metil-2,3,8,9,9b-pentaaza-ciclopenta [a] naftalenos | |
UY36875A (es) | Composiciones inhibidoras de bromodominios para el tratamiento de diversas enfermedades | |
BR112015020139A2 (pt) | compostos terapêuticos e usos dos mesmos | |
DOP2015000170A (es) | Compuestos químicos | |
SV2018005760A (es) | Derivados de aminotiazol utiles como agentes antiviricos | |
EA201790949A1 (ru) | Замещенные 2,4-диаминохинолины в качестве новых противораковых средств | |
BR112017009012A2 (pt) | derivados de anel benzo de seis membros como inibidor de dpp-4 e seu uso | |
CR20170513A (es) | Derivados de pirazol útiles como inhibidores de proteína activadora de 5-li-poxigenasa (flap). | |
UY37729A (es) | NUEVOS COMPUESTOS QUE INHIBEN LA ACTIVIDAD DE Nav1.7 | |
UY33723A (es) | ?COMPUESTOS Y SU USO PARA TRATAMIENTO DE ENFERMEDADES RELACIONADAS CON Aß?. | |
BR112015015250A2 (pt) | derivados de pirrolidina, composições farmacêuticas e usos dos mesmos |